Down-regulation of stathmin is required for TGF-β inducible early gene 1 induced growth inhibition of pancreatic cancer cells

Cancer Letters

Volumn 274, Issue 1, 2009, Pages 101-108

  Jiang, Lei ^a,b   Chen, Yangchao ^b   Chan, Chu yan ^b   Wang, Xin ^b   Lin, Lin ^c   He, Ming liang ^b   Lin, Marie C M ^d   Yew, David T ^b   Sung, Joseph J Y ^b   Li, Ji Cheng ^a   Kung, Hsiang fu ^b  

^a ZHEJIANG UNIVERSITY   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Apoptosis; Chemosensitivity; Pancreatic cancer; Stathmin; TIEG1

Indexed keywords

GEMCITABINE; LENTIVIRUS VECTOR; SMALL INTERFERING RNA; STATHMIN; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CANCER RESISTANCE; CHEMOSENSITIVITY; DOWN REGULATION; EARLY RESPONSE GENE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN TARGETING; TRANSFORMING GROWTH FACTOR BETA INDUCIBLE EARLY GENE 1; VIRAL GENE DELIVERY SYSTEM;

ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; BLOTTING, WESTERN; CELL PROLIFERATION; DEOXYCYTIDINE; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; EARLY GROWTH RESPONSE TRANSCRIPTION FACTORS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; PANCREATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBONUCLEOTIDE REDUCTASES; RNA, MESSENGER; RNA, SMALL INTERFERING; STATHMIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 57749084479     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.09.017     Document Type: Article

References (36)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J., Smigal C., et al. Cancer statistics, 2006, CA. Cancer J. Clin. 56 (2006) 106-130
2. Rane S.G., Lee J.H., and Lin H.M. Transforming growth factor-beta pathway: role in pancreas development and pancreatic disease. Cytokine Growth Factor Rev. 17 (2006) 107-119
3. Truty M.J., and Urrutia R. Basics of TGF-beta and pancreatic cancer. Pancreatology 7 (2007) 423-435
4. Fautsch M.P., Vrabel A., Rickard D., Subramaniam M., Spelsberg T.C., and Wieben E.D. Characterization of the mouse TGFbeta-inducible early gene (TIEG): conservation of exon and transcriptional regulatory sequences with evidence of additional transcripts. Mamm. Genome 9 (1998) 838-842
5. Subramaniam M., Hefferan T.E., Tau K., Peus D., Pittelkow M., Jalal S., et al. Tissue, cell type, and breast cancer stage-specific expression of a TGF-beta inducible early transcription factor gene. J. Cell Biochem. 68 (1998) 226-236
6. Cook T., Gebelein B., Mesa K., Mladek A., and Urrutia R. Molecular cloning and characterization of TIEG2 reveals a new subfamily of transforming growth factor-beta-inducible Sp1-like zinc finger-encoding genes involved in the regulation of cell growth. J. Biol. Chem. 273 (1998) 25929-25936
7. Tachibana I., Imoto M., Adjei P.N., Gores G.J., Subramaniam M., Spelsberg T.C., et al. Overexpression of the TGFbeta-regulated zinc finger encoding gene, TIEG, induces apoptosis in pancreatic epithelial cells. J. Clin. Invest. 99 (1997) 2365-2374
8. Blok L.J., Grossmann M.E., Perry J.E., and Tindall D.J. Characterization of an early growth gene, responsewhich encodes a zinc finger transcription factor potentially involved in cell cycle regulation. Mol. Endocrinol. 9 (1995) 1610-1620
9. Yajima S., Lammers C.H., Lee S.H., Hara Y., Mizuno K., and Mouradian M.M. Cloning and characterization of murine glial cell-derived neurotrophic factor inducible transcription factor (MGIF). J. Neurosci. 17 (1997) 8657-8666
10. Cook T., Gebelein B., Belal M., Mesa K., and Urrutia R. Three conserved transcriptional repressor domains are a defining feature of the TIEG subfamily of Sp1-like zinc finger proteins. J. Biol. Chem. 274 (1999) 29500-29504
11. Subramaniam M., Hawse J.R., Johnsen S.A., and Spelsberg T.C. Role of TIEG1 in biological processes and disease states. J. Cell Biochem. 102 (2007) 539-548
12. Eid M.A., Kumar M.V., Iczkowski K.A., Bostwick D.G., and Tindall D.J. Expression of early growth response genes in human prostate cancer. Cancer Res. 58 (1998) 2461-2468
13. Chen G.G., Xu H., Lee J.F., Subramaniam M., Leung K.L., Wang S.H., et al. 15-Hydroxy-eicosatetraenoic acid arrests growth of colorectal cancer cells via a peroxisome proliferator-activated receptor gamma-dependent pathway. Int. J. Cancer 107 (2003) 837-843
14. Cook T., and Urrutia R. TIEG proteins join the Smads as TGF-beta-regulated transcription factors that control pancreatic cell growth. Am. J. Physiol. Gastrointest. Liver Physiol. 278 (2000) G513-G521
15. Antonello D., Moore P.S., Zamboni G., Falconi M., and Scarpa A. Absence of mutations in the transforming growth factor-beta inducible early gene 1, TIEG1, in pancreatic cancer. Cancer Lett. 183 (2002) 179-183
16. Reinholz M.M., An M.W., Johnsen S.A., Subramaniam M., Suman V.J., Ingle J.N., et al. Differential gene expression of TGF beta inducible early gene (TIEG), Smad7, Smad2 and Bard1 in normal and malignant breast tissue. Breast Cancer Res. Treat. 86 (2004) 75-88
17. Chalaux E., Lopez-Rovira T., Rosa J.L., Pons G., Boxer L.M., Bartron R., et al. A zinc-finger transcription factor induced by TGF-beta promotes apoptotic cell death in epithelial Mv1Lu cells. FEBS Lett. 457 (1999) 478-482
18. Schleger C., Arens N., Zentgraf H., Bleyl U., and Verbeke C. Identification of frequent chromosomal aberrations in ductal adenocarcinoma of the pancreas by comparative genomic hybridization (CGH). J. Pathol. 191 (2000) 27-32
19. Shiraishi K., Okita K., Kusano N., Harada T., Kondoh S., Okita S., et al. A comparison of DNA copy number changes detected by comparative genomic hybridization in malignancies of the liver, biliary tract and pancreas. Oncology 60 (2001) 151-161
20. Sato N., Mizumoto K., Nakamura M., Maehara N., Minamishima Y.A., Nishio S., et al. Correlation between centrosome abnormalities and chromosomal instability in human pancreatic cancer cells. Cancer Genet. Cytogenet. 126 (2001) 13-19
21. Teraoka H., Sawada T., Nishihara T., Yashiro M., Ohira M., Ishikawa T., et al. Enhanced VEGF production and decreased immunogenicity induced by TGF-beta 1 promote liver metastasis of pancreatic cancer. Br. J. Cancer 85 (2001) 612-617
22. Furukawa T., Duguid W.P., Rosenberg L., Viallet J., Galloway D.A., and Tsao M.S. Long term culture and immortalization of epithelial cells from normal adult human pancreatic ducts by transfection with the E6E7 gene of human papilloma virus 16. Am. J. Pathol. 148 (1996) 1763-1770
23. Ouyang H., Mou L.J., Luk C., Liu N., Squire J., and Tsao M.S. Paradiploid human pancreatic duct epithelial cell lines with near normal phenotype. Am. J. Pathol. 157 (2000) 1623-1631
24. Chen Y., Lin M.C., Yao H., Wang H., Zhang A.Q., Yu J., et al. Lentivirus-mediated RNA interference targeting enhancer of zeste homolog 2 inhibits hepatocellular carcinoma growth through down-regulation of stathmin. Hepatology 46 (2007) 200-208
25. Chen Y., Lin M.C., Wang H., Chan C.Y., Jiang L., Ngai S.M., et al. Proteomic analysis of EZH2 downstream target proteins in hepatocellular carcinoma. Proteomics 7 (2007) 3097-3104
26. Iancu-Rubin C., and Atweh G.F. p27(Kip1) and stathmin share the stage for the first time. Trends Cell Biol. 15 (2005) 346-348
27. Iacobuzio-Donahue C.A., Maitra A., Shen-Ong G.L., van Heek T., Ashfaq R., Meyer R., et al. Discovery of novel tumor markers of pancreatic cancer using global gene expression technology. Am. J. Pathol. 160 (2002) 1239-1249
28. Kleeff J., Ishiwata T., Maruyama H., Friess H., Truong P., Buchler M.W., et al. The TGF-beta signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer. Oncogene 18 (1999) 5363-5372
29. Kunnumakkara A.B., Guha S., Krishnan S., Diagaradjane P., Gelovani J., and Aggarwal B.B. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products. Cancer Res. 67 (2007) 3853-3861
30. Nakano Y., Tanno S., Koizumi K., Nishikawa T., Nakamura K., Minoguchi M., et al. Gemcitabine chemoresistance and molecular markers associated with gemcitabine transport and metabolism in human pancreatic cancer cells. Br. J. Cancer 96 (2007) 457-463
31. Yu C., Zhang X., Sun G., Guo X., Li H., You Y., et al. RNA interference-mediated silencing of the polo-like kinase 1 gene enhances chemosensitivity to gemcitabine in pancreatic adenocarcinoma cells. J. Cell Mol. Med. (2008) Feb 5. (Epub ahead of print)
32. Subramaniam M., Harris S.A., Oursler M.J., Rasmussen K., Riggs B.L., and Spelsberg T.C. Identification of a novel TGF-beta-regulated gene encoding a putative zinc finger protein in human osteoblasts. Nucleic Acids Res. 23 (1995) 4907-4912
33. Baldassarre G., Belletti B., Nicoloso M.S., Schiappacassi M., Vecchione A., Spessotto P., et al. p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion. Cancer Cell 7 (2005) 51-63
34. Alli E., Yang J.M., and Hait W.N. Silencing of stathmin induces tumor-suppressor function in breast cancer cell lines harboring mutant p53. Oncogene 26 (2007) 1003-1012
35. Rubin C.I., and Atweh G.F. The role of stathmin in the regulation of the cell cycle. J. Cell Biochem. 93 (2004) 242-250
36. Kouzu Y., Uzawa K., Koike H., Saito K., Nakashima D., Higo M., et al. Overexpression of stathmin in oral squamous-cell carcinoma: correlation with tumour progression and poor prognosis. Br. J. Cancer 94 (2006) 717-723